Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Clemson University's first African American woman to become a tenured professor at Clemson University's College of Education ...

The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...

LEANNE Battersby looks set to be left rattled in the coming days on Coronation Street. Over the past few months, fans of the ...

Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...

Medicine is on the precipice of radical changes in diagnosis, personalised treatment, and the ability to prevent disease ...

The Indian Medical Association (IMA) on Wednesday condemned the attack on an oncologist by a patient's family member at a ...